Biomarkers in Samples From Patients With Endometrial Cancer

Trial number:
Trial phase:
Study type:
Observational, Biomarker
Overall status:
Not yet recruiting

Study start date

January, 2100

Scientific title

Specialized Program of Research Excellence (SPORE) in Endometrial Cancer


This research study is studying biomarkers in samples from patients with endometrial cancer. Studying samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

Inclusion Criteria:

Samples available from one of the following:

GOG-0210Washington University School of Medicine Siteman Cancer Center

Study design

Time perspective: Retrospective,


Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer

Other study ID numbers

GOG-8020; NCI-2011-02868; GOG-8020; CDR0000684553; GOG-8020; GOG-8020; P50CA134254; R01CA071754; R21CA133295; U10CA027469; U10CA037517

Choose trial site (1)